Single Anastomosis Sleeve Jejunal (SAS-J) Bypass

Morbid Obesity Clinical Trial

Official title:

Single Anastomosis Sleeve Jejunal (SAS-J) Bypass as A Treatment for Morbid Obesity

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02870530
• Other study ID #: fac.med.016
• Status: Completed
• Phase: N/A
• Start date: November 2016
• Est. completion date: April 2017

Study information

• Verified date: February 2022
• Source: Minia University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to determine the efficacy of single anastomoses sleeve jejunal bypass as a treatment for morbid obesity

Description:

in this study the investigators aim to test a new technique ( single anastomoses sleeve jejunal as a treatment for morbid obesity Which is a modification of Single anastomoses sleeve ileal bypass with short biliary limb ( about one third of the small intestine from the Duodeno-jejunal junction

Recruitment information / eligibility

• Status: Completed
• Enrollment: 200
• Est. completion date: April 2017
• Est. primary completion date: April 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 50 Years

Eligibility

Inclusion Criteria:

• obese patients with BMI more than 40

• patients fit for laparoscopic surgery

• give approval to share in the study

Exclusion Criteria:

• patients refused to share in the study

• patients unfit for surgery

• patients aged less than 18 and older than 50

• patients with BMI less than 50

• patient with previous upper abdominal surgery either for obesity or other diseases

• patients with preoperative GERD clinically or by investigation

Related Conditions & MeSH terms

• Morbid Obesity
• Obesity
• Obesity, Morbid

Intervention

Procedure:
• Single Anastomosis Sleeve Jejunal (SAS-J) Bypass
Single Anastomosis Sleeve Jejunal (SAS-J) Bypass as A treatment for Morbid

Locations

Country	Name	City	State
Egypt	Minia university hospital	Minya

Sponsors (1)

Lead Sponsor	Collaborator
Minia University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	postoperative biliary reflux	the presence of postoperative biliary reflux clinically and by upper endoscopy	3 months
Primary	operative time	the operative time from skin incision to skin closure	the 1st 24 hours
Primary	intraoperative complications	intraoperative complications like bleeding, other organs injuries	the 1st 24 hours
Primary	the postoperative weight loss	the percentage of weight loss from total excess body weight	12 month
Secondary	effect on metabolic syndrome if present	effect on blood sugar level, blood pressure and blood cholesterol level	12 months